Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 46(8): 1172-80, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18444852

ABSTRACT

BACKGROUND: The largest reported mumps outbreak at a US college in 19 years occurred in 2006 at a Kansas university with a 2-dose measles-mumps-rubella (MMR) vaccination policy. We assessed vaccine performance and mumps risk factors, including the possibility of waning vaccine protection. METHODS: Case students were compared with a cohort of the university's approximately 19,000 undergraduates. The secondary attack rate for clinical mumps was determined among roommates exposed to case students. Time from receipt of the second dose of MMR vaccine was compared between case students and roommates without mumps. RESULTS: Coverage with > or =2 dose of MMR vaccine was > or =95% among 140 undergraduate case students and 444 cohort students. The secondary attack rate for clinical mumps among roommates who had received 2 doses of vaccine ranged from 2.2% to 7.7%, depending on the case definition. Compared with roommates without mumps, case students were more likely (odds ratio, 2.46; 95% confidence interval, 1.25-4.82) to have received their second dose of MMR vaccine > or =10 years earlier. The odds of being a case student increased with each 1-year increase in time from receipt of the second dose of MMR vaccine (odds ratio, 1.36; 95% confidence interval, 1.10-1.68) among case students and roommates aged 18-19 years but not among those aged > or =20 years. Students aged 18-19 years had a higher risk of mumps (risk ratio, 3.14; 95% confidence interval, 1.60-6.16), compared with students aged > or =22 years; women living in dormitories had increased risk of mumps (risk ratio, 1.95; 95% confidence interval, 1.01-3.76), compared with men not living in dormitories. CONCLUSION: High 2-dose MMR coverage protected many students from developing mumps but was not sufficient to prevent the mumps outbreak. Vaccine-induced protection may wane. Similar US settings where large numbers of young adults from wild-type naive cohorts live closely together may be at particular risk for mumps outbreaks.


Subject(s)
Measles-Mumps-Rubella Vaccine/immunology , Mumps Vaccine/immunology , Mumps/immunology , Students/statistics & numerical data , Cohort Studies , Disease Outbreaks , Female , Humans , Kansas/epidemiology , Male , Measles-Mumps-Rubella Vaccine/administration & dosage , Mumps/epidemiology , Mumps/prevention & control , Mumps Vaccine/administration & dosage , Universities
2.
Am J Ind Med ; 50(4): 245-60, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17311255

ABSTRACT

BACKGROUND: The combined effect of socioeconomic, organizational, psychosocial, and physical factors on work-related musculoskeletal disorders (WRMSDs) were studied in a heterogeneous, socioeconomically diverse sample (cases and their matched referents) of hospital workers. METHODS: Cases were defined by a new acute or cumulative work-related musculoskeletal injury; referents were matched by job group, shift length, or at random. Information was obtained through telephone interviews and on-site ergonomics observation. Questionnaire items included sociodemographic variables, lost work time, work effectiveness, health status, pain/disability, and psychosocial working conditions using Effort Reward Imbalance (ERI) and Demand-Control (DC) models. Two multivariate models were tested: Model 1 included occupation as a predictor; Model 2 included education-income as a predictor. RESULTS: Cases reported greater pain, disability, lost time, and decreased work effectiveness than the referents. Model 1 was statistically significant for neck/upper extremity injury (Chi-square = 19.3, P = 0.01), back/lower extremity injury (Chi-square = 14.0, P = 0.05), and all injuries combined (Chi-square = 25.4, P = 0.001). "Other Clinical" occupations (34% mental health workers) had the highest risk of injury (OR 4.5: 95%CI, 1.7-12.1) for all injuries. The ERI ratio was a significant predictor for neck and upper extremity (OR 1.5: 95%CI, 1.1-1.9) and all injuries (OR 1.3; 95%CI, 1.04-1.5), per SD change in score. CONCLUSIONS: In this study, the risk of WRMSDs was more strongly influenced by specific psychosocial and physical job-related exposures than by broad socioeconomic factors such as education and income.


Subject(s)
Musculoskeletal Diseases/epidemiology , Occupational Health/statistics & numerical data , Personnel, Hospital/statistics & numerical data , Social Class , Workload , Workplace , Adult , Case-Control Studies , Ergonomics , Female , Humans , Male , Middle Aged , Multivariate Analysis , Musculoskeletal Diseases/physiopathology , Personnel, Hospital/psychology , Prospective Studies , Risk Assessment , Risk Factors , Surveys and Questionnaires , United States/epidemiology , Workload/psychology , Workplace/psychology
3.
Pharmacol Biochem Behav ; 71(1-2): 197-204, 2002.
Article in English | MEDLINE | ID: mdl-11812523

ABSTRACT

Instrumental responding for intravenous cocaine in rats at 85% of free-feeding weight was significantly decreased 50% by D-fenfluramine plus phentermine (D-Fen/Phen, 5 mg/kg of each for 1 day). A similar effect was obtained in normal-weight rats self-administering a cocaine-heroin mixture. Treating normal-weight animals with fluoxetine (5 mg/kg) for 4 days also significantly decreased cocaine self-administration by half, and then adding phentermine caused an additional decrease in cocaine intake. Animals that were well trained to self-administer drug did not self-administer intravenous D-Fen/Phen or Flu/Phen. The present results confirm that serotonergic drugs can decrease cocaine, or cocaine/heroin, self-administration in rats, and that phentermine adds to the effect. Based on related research with the same dose of D-Fen/Phen, it is suggested that effectiveness in reducing cocaine reinforcement is due in part to a satiating effect in which dopamine and acetylcholine are released in the nucleus accumbens.


Subject(s)
Appetite Depressants/administration & dosage , Cocaine/administration & dosage , Dopamine Uptake Inhibitors/administration & dosage , Fenfluramine/administration & dosage , Fluoxetine/administration & dosage , Selective Serotonin Reuptake Inhibitors/administration & dosage , Animals , Appetite Depressants/therapeutic use , Behavior, Addictive/prevention & control , Cocaine/antagonists & inhibitors , Dopamine Uptake Inhibitors/antagonists & inhibitors , Drug Therapy, Combination , Fenfluramine/therapeutic use , Fluoxetine/therapeutic use , Injections, Intravenous , Male , Rats , Rats, Sprague-Dawley , Self Administration/statistics & numerical data , Selective Serotonin Reuptake Inhibitors/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...